Results for tag: "Bladder Drug"

The Bladder Drug market is a subset of the Urological Disorders Drugs market, which focuses on treatments for conditions related to the urinary tract. These drugs are used to treat a variety of conditions, including urinary incontinence, overactive bladder, bladder cancer, and urinary tract infections. Bladder drugs are typically administered orally, topically, or through injections. Commonly prescribed bladder drugs include anticholinergics, antispasmodics, and alpha-blockers. The Bladder Drug market is highly competitive, with a range of generic and branded products available. Companies in the market include Astellas Pharma, Allergan, Pfizer, Merck, and Sanofi. Show Less Read more